stockcue

REGN (Regeneron Pharmaceuticals, Inc.): risk score 78/100 — Strong Buy · Valuation 75/100 · Financial health 100/100 · Growth 57/100 · price $624.72. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s